START Center for Cancer Research at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

START Center for Cancer Research brings 3 presentations to ENA 2026 in Barcelona. Its program centres on early-phase trials of new agents, from multispecific immune engagers to radiopharmaceuticals. It also reports the safety and early activity of MTA-cooperative PRMT5 inhibitors in patients with advanced solid tumors treated in a phase I unit.

OrganizationENA 2026 Attendance
startresearch.com
Cancer centres & hospitals
Network of early-phase oncology clinical trial sites in the United States and Europe, including units in Madrid.
Talk
Wed Nov 18
3–3:20pm
Session
Wed Nov 18
4:15–5:45pm
Workshop 2: Radiopharmaceuticals
ADCs & radioligands
Poster
Fri Nov 20
10:45–11:15am
1:30–3pm

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from START Center for Cancer Research

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction